Tenon Medical, Inc. Announces Timing of Fourth Quarter and Full Year 2023 Financial Results
Tenon Medical, Inc. Announces Timing of Fourth Quarter and Full Year 2023 Financial Results
LOS GATOS, CA / ACCESSWIRE / February 27, 2024 / Tenon Medical, Inc. (NASDAQ:TNON) ("Tenon" or the "Company"), a company transforming care for patients suffering with certain sacroiliac joint (SI Joint) disorders, today announced plans to release financial results for the fourth quarter and full year 2023 ended December 31, 2023 after market close on Tuesday, March 12, 2024. The Company will also hold a conference call the same day at 4:30 p.m. Eastern Time to discuss its financial results in further detail. The call will conclude with a Q&A session with its covering analysts.
加利福尼亚州洛斯加托斯/ACCESSWIRE/2024年2月27日/Tenon Medical, Inc.（纳斯达克股票代码：TNON）（“Tenon” 或 “公司”）是一家为某些骶骶骶关节（SI关节）患者提供护理服务的公司，今天宣布计划在2024年3月12日星期二收盘后发布截至2023年12月31日的第四季度和2023年全年财务业绩。该公司还将在美国东部时间当天下午 4:30 举行电话会议，进一步详细讨论其财务业绩。电话会议将以与其报道分析师的问答环节结束。
| Date: | Tuesday, March 12, 2024 |
| Time: | 4:30 p.m. Eastern time |
| Dial-in: | 1-877-407-0792 |
| International Dial-in: | 1-201-689-8263 |
| Webcast: | TNON Conference Call |
| 日期： | 2024年3月12日，星期二 |
| 时间： | 美国东部时间下午 4:30 |
| 拨入： | 1-877-407-0792 |
| 国际拨入： | 1-201-689-8263 |
| 网络直播： | TNON 电话会议 |
Please dial in at least 10 minutes before the start of the call to ensure timely participation.
请在通话开始前至少 10 分钟拨号，以确保及时参与。
An audio playback of the call will be available through March 26, 2024, on Tenon's Investor Relations website at or via telephone replay by dialing 1-844-512-2921(USA) or 1-412-317-6671 (International). The access code will be 13744319.
该电话会议的音频将在2024年3月26日之前在Tenon的投资者关系网站上播放，电话号码是拨打1-844-512-2921（美国）或1-412-317-6671（国际），也可以通过电话重播。接入码将是 13744319。
About Tenon Medical, Inc.
关于 Tenon Medical, Inc.
Tenon Medical, Inc., a medical device company formed in 2012, has developed The Catamaran SI Joint Fusion System that offers a novel, less invasive approach to the SI joint using a single, robust titanium implant. The system features the Catamaran Fixation Device which passes through both the axial and sagittal planes of the ilium and sacrum, stabilizing and transfixing the SI Joint along its longitudinal axis. The angle and trajectory of the Catamaran surgical approach is also designed to provide a pathway away from critical neural and vascular structures and into the strongest cortical bone. Since the national launch of the Catamaran SI Joint Fusion System in October 2022 Tenon is focused on three commercial opportunities with its System in the SI Joint market which includes: 1) Primary SI Joint procedures, 2) Revision procedures of failed SI Joint implants and 3) SI Joint fusion adjunct to a spine fusion construct. For more information, please visit
成立于2012年的医疗器械公司Tenon Medical, Inc. 开发了双体船SI关节融合系统，该系统使用单一坚固的钛植入物为SI关节提供了一种新颖的、侵入性较小的方法。该系统采用双体船固定装置，该装置穿过髂骨和骶骨的轴向和矢状面，沿其纵轴稳定和穿过SI关节。双体船手术方法的角度和轨迹还旨在提供一条远离关键神经和血管结构并进入最强皮质骨的途径。自2022年10月双体船SI关节融合系统在全国上线以来，Tenon一直专注于其系统在SI关节市场的三个商业机会，其中包括：1) 初级SI关节手术，2) 失败的SI关节植入物的修订程序以及3) 脊柱融合结构的辅助SI关节融合术。欲了解更多信息，请访问
The Tenon Medical logo, Tenon Medical and Catamaran are registered trademarks of Tenon Medical, Inc.
Tenon Medical 徽标、Tenon Medical 和 Catamaran 是 Tenon Medical, Inc. 的注册商标。
Investor Contact
Shannon Devine
MZ North America
203-741-8811
tenon@mzgroup.us
投资者联系人
香农迪瓦恩
MZ 北美
203-741-8811
tenon@mzgroup.us
SOURCE: Tenon Medical, Inc.
来源：Tenon Medical, Inc.
译文内容由第三方软件翻译。